Jeffrey Parkin

US Patent 7179470 Hepatitis-C virus testing

US Patent 7300918 Method of producing vaccines from protein signal oligopeptides

US Patent 7318926 Glycosylated specificity exchangers

US Patent 7326417 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses

US Patent 7348136 Method and device for detecting feline immunodeficiency virus

US Patent 7407661 Methods and reagents that generate a CD8 T cell immune response

US Patent 7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide

US Patent 7671038 Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides

US Patent 7691382 Antiviral polypeptides comprising tandem repeats of APOE 141-149 and variants thereof

US Patent 7943139 Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates

US Patent 7981430 Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome

US Patent 7981431 Consensus dengue virus envelope protein domain III polypeptides (cED III) and their methods of use

US Patent 7988975 Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies

US Patent 7989161 Methods for determining human immunodeficiency virus type 2 (HIV-2) protease sensitivity or resistance to antivirals utilizing an inducible yeast expression system

US Patent 7993651 Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes

US Patent 7994278 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)